Oncoheroes Biosciences is now at a crucial moment in its quest to find effective therapies for pediatric cancer patients, as they have the unprecedented opportunity to test Volasertib, one of its thre...
Read more
SparingVision today announces a key advancement in its Phase I/II clinical trial for SPVN06, the Company’s lead gene-agnostic investigational gene therapy for the treatment of retinitis pigmentosa (...
Read more
Researchers at the University of Barcelona (UB) are taking part in a consortium working on the research and development of a new drug to treat the cognitive and motor decline associated with the disea...
Read more
Collaboration will support the initiation of a combination arm in the ongoing Phase 1/2a trial in patients with mCRPC
Read more
They are evaluating the combination of nivolumab plus ipilimumab versus chemotherapy as first-line treatment in patients with a subtype of metastatic colorectal cancer called MSI-H/dMMR. The first res...
Read more
El objetivo del ensayo clínico SIMPLIFY era comprobar en estos pacientes, tratados inicialmente con un antibiótico de amplio espectro (activo frente a muchas bacterias, incluyendo bacterias multirre...
Read more
El Hospital de Bellvitge supera ya los 100 pacientes tratados de tumores neuroendocrinos con esta terapia personalizada, reforzada por los buenos resultados de los últimos estudios
Read more
Dos recientes estudios ofrecen importantes avances en la utilización de terapia génica como tratamiento para la pérdida auditiva.
Read more
Results of the first-in-human phase I trial of OMO-103 demonstrate its safety and promising anti-tumor activity and shows how this MYC inhibitor can stabilize or even reduce disease burden in some hea...
Read more
An international clinical trial is underway to evaluate on a large scale the effects of the first specific treatment for Polycystic Ovary Syndrome, a condition that affects between 5 and 10% of women ...
Read more
Proceeds from the financing will be used to advance the company’s pipeline of wholly-owned, off-the-shelf cell therapies for multiple indications, including its lead investigational candidate, NRTX-...
Read more
The investment will be used to complete three phase II clinical trials in which the efficacy of its most advanced products is being studied, namely PBF-680 in patients with chronic obstructive pulmona...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
